Literature DB >> 26938367

Complementary and Alternative Medicine Use by Normal Weight, Overweight, and Obese Patients with Arthritis or Other Musculoskeletal Diseases.

Justice Mbizo1, Anthony Okafor2, Melanie A Sutton1, Erica N Burkhart1, Leauna M Stone1.   

Abstract

OBJECTIVES: The Centers for Disease Control and Prevention estimates that 50 million Americans have been diagnosed with arthritis and other musculoskeletal diseases. The purpose of the current study was to (1) estimate the prevalence of overall complementary and alternative medicine (CAM) use and (2) examine the role of body mass index (BMI) on CAM use among normal weight, overweight, and obese persons with chronic lower back pain, chronic neck pain, chronic/rheumatoid arthritis, or musculoskeletal diseases, while controlling for other covariates.
DESIGN: Cross-sectional design using secondary data for 9724 adults from the 2007 National Health Interview Survey. Data were weighted and analyzed by using Stata 12 for Windows (Stata Corp., College Station, TX). Descriptive, bivariate, and multivariate logistic regression statistics were computed. PARTICIPANTS: The participants were randomly surveyed from U.S. households. OUTCOME MEASURES: CAM use was measured as reported use of any modality within the five National Center for Complementary and Integrative Health domains.
RESULTS: CAM use was statistically significantly associated with female sex; race/ethnicity; having chronic neck pain, lower back pain, or chronic/rheumatoid arthritis; having limitations due to chronic disease; and geographic region (p < 0.05). Factors significantly associated with decreased odds of CAM use included age 50-64 years, income categorized as "other/missing," and having musculoskeletal diseases. Stratification by body mass index suggested increased odds of CAM use among normal/underweight persons with chronic neck pain but decreased odds for those with chronic musculoskeletal diseases. For overweight patients, increased odds of CAM use were significant for chronic lower back pain, musculoskeletal diseases, and chronic/rheumatoid arthritis.
CONCLUSIONS: Musculoskeletal diseases and arthritis represent important public health problems with economic implications for the well-being of individuals and society. Identifying CAM use trends by patient weight can be used to improve strategies to increase awareness and access to CAM as part of comprehensive and cost-effective approaches for the management and treatment of these conditions.

Entities:  

Mesh:

Year:  2016        PMID: 26938367     DOI: 10.1089/acm.2014.0390

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  4 in total

1.  Prevalence of self-reported knee symptoms and management strategies among elderly individuals from Frederiksberg municipality: protocol for a prospective and pragmatic Danish cohort study.

Authors:  Elisabeth Marie Ginnerup-Nielsen; Marius Henriksen; Robin Christensen; Berit Lilienthal Heitmann; Roy Altman; Lyn March; Anthony Woolf; Hanne Karlsen; Henning Bliddal
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

2.  Estimating the Prevalence of Knee Pain and the Association between Illness Perception Profiles and Self-Management Strategies in the Frederiksberg Cohort of Elderly Individuals with Knee Pain: A Cross-Sectional Study.

Authors:  Elisabeth Ginnerup-Nielsen; Robin Christensen; Berit L Heitmann; Roy D Altman; Lyn March; Anthony Woolf; Henning Bliddal; Marius Henriksen
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

Review 3.  The Role of Natural Products in Rheumatoid Arthritis: Current Knowledge of Basic In Vitro and In Vivo Research.

Authors:  Georgia-Eirini Deligiannidou; Vasiliki Gougoula; Eugenia Bezirtzoglou; Christos Kontogiorgis; Theodoros K Constantinides
Journal:  Antioxidants (Basel)       Date:  2021-04-13

4.  Gender Differences in the Prevalence of Complementary and Alternative Medicine Utilization among Adults with Arthritis in the United States.

Authors:  Monira Alwhaibi; Yazed AlRuthia; Abdulkarim M Meraya
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-03       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.